4 articles
India's food safety regulator issued notices to Nestle, Zydus, and Abbott regarding promotional claims for infant and children's products. This regulatory crackdown follows proposed bans on added suga
Abbott settled for $670 million to resolve 2,000 claims alleging its Similac infant formulas caused necrotizing enterocolitis in preterm infants. The agreement includes a prior $495 million verdict ag
Abbott raised its 2026 profit forecast after beating quarterly estimates, driven by strong demand in its acquired cancer diagnostics business and medical devices segments, offsetting declines in COVID
Abbott exceeded quarterly profit and revenue expectations driven by its medical device unit, though shares fell after lowering its 2026 profit forecast by 20 cents per share due to the $23 billion Exa
ChemBrief